Physician profile
Christopher E Kelly
NPI 1366436081
$137,501.50
in general payments reported to CMS, 2019-2025
23 companies · $21K in 2025
The $21K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $86.29 · 2021: $720 · 2022: $20K · 2023: $37K · 2024: $59K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $95K · Food and Beverage: $9,528 · Honoraria: $6,500 · Travel and Lodging: $3,912 · Gift: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $95,250.00 |
| Food and Beverage | $9,528.18 |
| Honoraria | $6,500.00 |
| Travel and Lodging | $3,911.92 |
| Gift | $1,166.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $107,409.21 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Antares Pharma, INC. | $26,367.96 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $610.28 | 2019-2024 | Myrbetriq |
| Endo USA, INC. | $522.77 | 2024-2025 | Xiaflex, Aveed, Edex |
| Urogen Pharma, INC. | $387.84 | 2023-2025 | Jelmyto |
| Hollister Incorporated | $308.42 | 2022-2024 | Onli, Vapro, Infyna Chic |
| Endo Pharmaceuticals INC. | $292.01 | 2020-2024 | Edex, Xiaflex, Aveed |
| Abc Home Medical Supply, INC. | $247.02 | 2022-2025 | |
| Olympus America INC. | $239.69 | 2023-2025 | Itind System |
| Dentsply Ih Ab | $181.93 | 2023-2025 | Lofric, Lofric |
| Dentsply Ih INC. | $143.35 | 2019-2022 | |
| Abbvie INC. | $143.22 | 2022-2024 | |
| Boston Scientific Corporation | $138.62 | 2019-2024 | Spaceoar Vue System - 10ml |
| Axonics, INC. | $126.51 | 2022 | |
| Teleflex LLC | $111.88 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $108.13 | 2019-2020 | |
| Coloplast Corp | $41.53 | 2021 | |
| Civco Medical Instruments | $25.88 | 2024 | |
| Allergan, INC. | $23.55 | 2019 | |
| Millicent US INC | $20.10 | 2025 | Intrarosa |
| Bard Peripheral Vascular, INC. | $19.28 | 2024 | Venovo |
| Novo Nordisk INC | $16.38 | 2024 | |
| Clarus Therapeutics INC. | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.